Clinical AI That Searches Everything At Once.
Type your clinical question. Prognia searches PubMed, current guidelines from ESC, AHA, NICE, ADA, GOLD, EULAR, KDIGO, and more — simultaneously. No switching tabs. No synthesising manually. Every answer cites its source.
Per ESC 2023 HF Guidelines, initiate four-pillar therapy simultaneously at low doses:
- 1.ARNI (sacubitril/valsartan) — preferred over ACE-I (Class I, Level B)
- 2.Beta-blocker — bisoprolol, carvedilol, or metoprolol succinate
- 3.MRA — eplerenone preferred over spironolactone with diabetes
- 4.SGLT2-i — dapagliflozin or empagliflozin (dual HF + T2DM benefit)
Every Query Searches 8 Authoritative Sources.
Prognia doesn't pick one source — it searches all of them and synthesises a coherent, cited answer.
PubMed
35M+ peer-reviewed papers
ESC Guidelines
European Society of Cardiology
AHA/ACC
American Heart Association
NICE
National Institute for Health and Care Excellence
ADA Standards
American Diabetes Association
GOLD
Global Initiative for COPD
EULAR
European Rheumatology guidelines
Clinical Cases
Curated real-world case database
Start Your Clinical AI Journey Today.
Search PubMed, compare guidelines, and track CPD — all in one place. Free forever. No credit card required.